| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.046 | 0.8 |